Greenrose Acquisition Corp Stock Current Valuation
Valuation analysis of Greenrose Acquisition helps investors to measure Greenrose Acquisition's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Greenrose Acquisition Corp OTC Stock Current Valuation Analysis
Greenrose Acquisition's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Greenrose Acquisition Current Valuation | 147.92 M |
Most of Greenrose Acquisition's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Greenrose Acquisition Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Greenrose Acquisition Corp has a Current Valuation of 147.92 M. This is 98.97% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current valuation for all United States stocks is 99.11% higher than that of the company.
Greenrose Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Greenrose Acquisition's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Greenrose Acquisition could also be used in its relative valuation, which is a method of valuing Greenrose Acquisition by comparing valuation metrics of similar companies.Greenrose Acquisition is currently under evaluation in current valuation category among its peers.
Greenrose Fundamentals
| Return On Equity | 0.35 | |||
| Return On Asset | -0.15 | |||
| Profit Margin | 0.47 % | |||
| Operating Margin | (1.46) % | |||
| Current Valuation | 147.92 M | |||
| Shares Outstanding | 17.68 M | |||
| Shares Owned By Insiders | 71.75 % | |||
| Shares Owned By Institutions | 15.15 % | |||
| Number Of Shares Shorted | 290.74 K | |||
| Price To Earning | 0.57 X | |||
| Price To Book | 0.48 X | |||
| Price To Sales | 0.25 X | |||
| Revenue | 28.4 M | |||
| Gross Profit | 18.68 M | |||
| EBITDA | (11.53 M) | |||
| Net Income | 83.3 M | |||
| Cash And Equivalents | 1.61 M | |||
| Cash Per Share | 0.09 X | |||
| Total Debt | 119.81 M | |||
| Debt To Equity | 2.38 % | |||
| Current Ratio | 0.15 X | |||
| Book Value Per Share | 0.82 X | |||
| Cash Flow From Operations | (47.71 M) | |||
| Short Ratio | 2.80 X | |||
| Earnings Per Share | 3.10 X | |||
| Number Of Employees | 91 | |||
| Beta | 0.32 | |||
| Market Capitalization | 12.2 M | |||
| Total Asset | 239.09 M | |||
| Net Asset | 239.09 M |
Thematic Opportunities
Explore Investment Opportunities
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Greenrose OTC Stock
If you are still planning to invest in Greenrose Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Greenrose Acquisition's history and understand the potential risks before investing.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |